Alla Arzumanyan - Y Combinator Founder of SFA Therapeutics
Home›Founders›Alla Arzumanyan
Alla Arzumanyan, Founder of SFA Therapeutics

Alla Arzumanyan

Founder at SFA Therapeutics

MS is Microbiology, PhD in Biotechnology, Assistant Professor at Temple University, Co-Founder and Co-Inventor at SFA Therapeutics, Inc. Performed a case-control, Proof-of-Activity Human study to evaluate treatment effect of SFA002 drug (proprietary of SFA Therapeutics, Inc.) on patients with plaque psoriasis. Worked with Axella Research on pre-IND application for SFA002. Worked with HEC (Sunshine Lake Pharma Co., China), Theravectys, and ThirdLaw LLC (still collaborating with the latter)

Previously at

Temple University
Temple University
Temple University College of Education
Temple University College of Education
Thomas Jefferson University
Thomas Jefferson University
Temple University - Lewis Katz School of Medicine
Temple University - Lewis Katz School of Medicine
Alumnus of
YSU, Armenia
YSU, Armenia